TriSalus Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	22.69	8.53	11.78	9.41	250.21	251.34
Cash & Short-Term Investments	22.69	8.53	11.78	9.41	250.21	251.34
Cash Growth	100.98%	-27.61%	25.10%	-96.24%	-0.45%	-
Accounts Receivable	5	5.09	3.55	1.56	-	-
Inventory	3.28	4.05	2.55	1.47	-	-
Other Current Assets	2.37	3.01	2.99	4.77	0.33	0.67
Total Current Assets	33.33	20.67	20.86	17.21	0.53	2.01
Net Property, Plant & Equipment	2.72	2.88	3.27	3.61	-	-
Other Intangible Assets	-	-	-	0.8	-	-
Other Long-Term Assets	0.42	0.42	0.47	0.37	-	-
Total Assets	36.46	23.97	24.6	22	250.53	252.01
Accounts Payable	3.78	2.27	3.39	4.95	1.06	0.1
Accrued Expenses	6.77	7.55	10.56	6.38	-	-
Short-Term Debt	-	-	-	-	0.54	-
Current Portion of Leases	0.13	0.22	0.35	0.37	-	-
Other Current Liabilities	0.22	0.38	0.39	20.66	-	-
Total Current Liabilities	10.91	10.23	14.69	32.36	1.6	0.1
Long-Term Debt	33.67	22.99	-	-	-	-
Long-Term Leases	1.31	1.54	1.24	1.59	-	-
Other Long-Term Liabilities	17.78	14.72	35.73	0.37	15.65	23.39
Total Long-Term Liabilities	52.76	39.25	36.98	1.96	15.65	23.39
Total Liabilities	63.19	49.87	51.66	34.32	17.25	23.5
Preferred Stock	-	-	-	164.01	-	-
Common Stock	0	0	0	-	0	0
Additional Paid-in Capital	294.24	253.65	222.44	10.03	-	-
Retained Earnings	-320.97	-279.55	-249.5	-186.36	-16.72	-21.49
Total Common Shareholders' Equity	-26.73	-25.89	-27.07	-176.33	-16.72	-21.48
Minority Interest	-	-	-	-	250	250
Shareholders' Equity	-26.73	-25.89	-27.07	-176.33	233.28	228.52
Total Liabilities & Equity	36.46	23.97	24.6	22	250.53	252.01
Total Debt	35.11	24.75	1.6	1.96	0.54	0
Net Cash (Debt)	-12.42	-16.22	10.18	7.45	249.66	251.34
Net Cash Growth	-	-	36.65%	-97.02%	-0.67%	-
Net Cash Per Share	-0.38	-0.64	1.08	24.07	1139.50	-
Book Value	-26.73	-25.89	-27.07	-176.33	-16.72	-21.48
Book Value Per Share	-0.81	-1.02	-2.88	-569.52	-76.30	-
Tangible Book Value	-26.73	-25.89	-27.07	-177.13	-16.72	-21.48
Tangible Book Value Per Share	-0.81	-1.02	-2.88	-572.12	-76.30	-

Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q